Carl Icahn Discusses His New Stake In Allergan

Billionaire investor confirmed through his Twitter account that he has acquired a "large position" in Allergan plc AGN. Shares of Allergan were trading higher by more than 2.50 percent after Tuesday's opening bell. Icahn also said in a statement is he is "very supportive" of the company's CEO Brent Saunders. Icahn's investment in Allergan doesn't mark the first time he has cooperated with Saunders. Icahn helped bring in Saunders as CEO of Forest Labs and the 2 " worked cooperatively and constructively" to "increase value for all Forest shareholders." Forest was ultimately acquired by Actavis which subsequently merged with Allergan. "We have every confidence in Brent's ability to enhance value for all Allergan shareholders," Icahn's statement also read.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsAllerganBrent SaundersCarl IcahnForest Labspharmaceutical companies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!